Rapid AST in sepsis management: Global perspectives on innovation and implementation
April 22, 2025, 15:00 BST / 16:00 CEST / 10:00 EDT / 07:00 PDT
Sepsis and bloodstream infections (BSIs) remain among the most urgent medical emergencies, requiring rapid intervention. The rising threat of antimicrobial resistance (AMR) further complicates treatment, particularly in regions with high resistance rates. Innovative diagnostic tools are critical to improving patient outcomes and combating the spread of resistance.
Rapid antimicrobial susceptibility testing (AST) systems, like the ultra-rapid QuickMIC® system, are revolutionizing infection management by providing clinically actionable MIC values within hours instead of days. These solutions empower clinicians to swiftly tailor antibiotic therapy, curb resistance selection, and enhance the clinical care of critically ill patients.
In this webinar, expert speakers from different AMR landscapes will share their insights and real-world experiences with rapid AST in sepsis management. Join us for a discussion on how rapid AST solutions are transforming laboratory workflows, supporting antimicrobial stewardship, and shaping the future of infection diagnostics.
Key learning objectives:
- Learn about emerging technologies within rapid antimicrobial susceptibility testing (AST) and their value to clinical microbiology labs
- Gain an understanding of how rapid AST methods are used to combat sepsis and antimicrobial resistance in different settings
- Explore real-world applications of rapid AST and examine its impact on laboratory workflows and patient care
Who should attend?
- Microbiologists
- Infectious disease clinicians
- Professionals working within clinical microbiology
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Speakers
Dr. Martin Sundqvist is a Senior Consultant in Clinical Microbiology at University Hospital Örebro, as well as an Associate Professor and Adjunct Lecturer at Örebro University. His research focuses on antibiotic resistance and susceptibility testing, including rapid AST from urine and positive blood cultures. He also explores optimizing microbiological diagnostics and has recently worked on projects utilizing metagenomic sequencing to accelerate species diagnosis in septic patients.
Dr. Alberto Antonelli's research in clinical microbiology involves evaluating and optimizing new diagnostic technologies in high AMR-impacted countries such as Italy.
Moderator
